These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36994643)

  • 61. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.
    Kim YS; Rhim H; Cho OK; Koh BH; Kim Y
    Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.
    Shiina S; Tateishi R; Arano T; Uchino K; Enooku K; Nakagawa H; Asaoka Y; Sato T; Masuzaki R; Kondo Y; Goto T; Yoshida H; Omata M; Koike K
    Am J Gastroenterol; 2012 Apr; 107(4):569-77; quiz 578. PubMed ID: 22158026
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Predictive Factors of Treatment Outcomes After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in the Hepatocaval Confluence: A Propensity Score Matching Analysis.
    Zhou Y; Yuan K; Yang Y; Shan X; Ji Z; Zhou D; Ouyang J; Wang Z; Zhang Q; Zhou J; Li Q
    Acad Radiol; 2023 Sep; 30 Suppl 1():S92-S103. PubMed ID: 37173236
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment Outcomes of Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: Effects of the Electrode Type and Placement Method.
    Park J; Lee MW; Ahn SH; Han S; Min JH; Cha DI; Song KD; Kang TW; Rhim H
    Korean J Radiol; 2023 Aug; 24(8):761-771. PubMed ID: 37500577
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Percutaneous radiofrequency ablation of tumor feeding artery before target tumor ablation may reduce local tumor progression in hepatocellular carcinoma.
    Cheng YT; Jeng WJ; Lin CC; Chen WT; Sheen IS; Lin CY; Lin SM
    Biomed J; 2016 Dec; 39(6):400-406. PubMed ID: 28043419
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Efficacy of microwave ablation in treatment of hepatocellular carcinoma within the Milan criteria: a report of 696 cases].
    Wang YM; Qian GJ; Xu Y; Wang N; Sheng YH
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):344-348. PubMed ID: 28763840
    [No Abstract]   [Full Text] [Related]  

  • 68. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
    Chen S; Shi M; Shen L; Qi H; Wan W; Cao F; Xie L; Wu Y; Chen G; Mo J; Zhu G; Ye D; Zhang Y; Feng Z; Xu L; Fan W
    Int J Hyperthermia; 2020; 37(1):384-391. PubMed ID: 32323585
    [No Abstract]   [Full Text] [Related]  

  • 69. Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure.
    Cha DI; Kang TW; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim K
    Eur Radiol; 2019 May; 29(5):2706-2715. PubMed ID: 30506222
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Radiofrequency Ablation Using a Separable Clustered Electrode for the Treatment of Hepatocellular Carcinomas: A Randomized Controlled Trial of a Dual-Switching Monopolar Mode Versus a Single-Switching Monopolar Mode.
    Choi JW; Lee JM; Lee DH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Cho EJ
    Korean J Radiol; 2021 Feb; 22(2):179-188. PubMed ID: 32729269
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Percutaneous thermal ablation of subcapsular hepatocellular carcinomas: influence of tumor-surface contact and protrusion on therapeutic efficacy and safety.
    Worakitsitisatorn A; Lu DS; Lee MW; Asvadi NH; Moshksar A; Yuen AD; McWilliams J; Raman SS
    Eur Radiol; 2020 Mar; 30(3):1813-1821. PubMed ID: 31822975
    [TBL] [Abstract][Full Text] [Related]  

  • 72. BCL6B hypermethylation predicts metastasis and poor prognosis in early-stage hepatocellular carcinoma after thermal ablation.
    Li X; Guo M; Yang L; Cheng Z; Yu X; Han Z; Liu F; Sun Q; Han X; Yu J; Liang P
    J Cancer Res Ther; 2021 Jul; 17(3):644-651. PubMed ID: 34269294
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
    Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
    Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation.
    Veltri A; Basile D; Calandri M; Bertaggia C; Volante M; Porpiglia F; Calabrese A; Puglisi S; Basile V; Terzolo M
    Eur Radiol; 2020 Dec; 30(12):6958-6964. PubMed ID: 32621242
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Local tumour control after radiofrequency or microwave ablation for colorectal liver metastases in relation to histopathological growth patterns.
    Vles MD; Höppener DJ; Galjart B; Moelker A; Vermeulen PB; Grünhagen DJ; Verhoef C
    HPB (Oxford); 2022 Sep; 24(9):1443-1452. PubMed ID: 35144863
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation.
    Lee DH; Lee JM; Yoon JH; Kim YJ; Han JK
    Radiology; 2017 Mar; 282(3):880-891. PubMed ID: 27643670
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver tumors.
    Sucandy I; Cheek S; Golas BJ; Tsung A; Geller DA; Marsh JW
    HPB (Oxford); 2016 Sep; 18(9):756-63. PubMed ID: 27593593
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression.
    Kaye EA; Cornelis FH; Petre EN; Tyagi N; Shady W; Shi W; Zhang Z; Solomon SB; Sofocleous CT; Durack JC
    Eur Radiol; 2019 May; 29(5):2698-2705. PubMed ID: 30402706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.